Why did Nvidia resume AI chip sales to China?
How are Trump's tariffs impacting US inflation?
What caused JPMorgan’s profit to fall despite beat?
Why are crypto bills stalling in the House?
How will Apple’s rare-earth deal affect supply chains?
What’s behind Tesla’s North American sales leadership exit?
How did BlackRock’s big client redemption affect shares?
Nurix Therapeutics price target lowered to $34 from $36 at H.C. Wainwright
finance.yahoo.com/news/nurix-therapeutics-price-target-lowered-141007727.html
In This Article:
H.C. Wainwright lowered the firm’s price target on Nurix Therapeutics (NRIX) to $34 from $36 and keeps a Buy rating on the shares. Nurix last week reported a Q2 net loss of (52c) per share, slightly narrower than the firm’s previously estimated net loss of (62c) per…
This story appeared on finance.yahoo.com, 2025-07-15 14:10:07.